SLQT

Business Context and Reporting Period

SelectQuote, Inc. (SLQT) is a technology-enabled direct-to-consumer distribution platform for insurance policies and healthcare services. The company operates three reportable segments: Senior (Medicare-related insurance), Healthcare Services (pharmacy and chronic care management), and Life (term and final expense insurance). This Form 10-Q covers the quarterly period ended September 30, 2025 (Fiscal Q1 2026).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 13% year-over-year, driven primarily by a 43% surge in Pharmacy revenue ($218.5 million) due to a 24% increase in SelectRx members. This growth offset a 21% decline in Commissions and other services revenue ($110.3 million).
• Segment Performance:
  • Senior: Revenue dropped 37% to $59.0 million, and Adjusted EBITDA swung from a $7.7 million profit to a $21.0 million loss. This was caused by a 27% decrease in approved policies due to regulatory changes limiting special enrollment periods.
  • Healthcare Services: Revenue grew 42% to $221.4 million, with Adjusted EBITDA improving to $7.2 million from $4.9 million.
  • Life: Revenue increased 19% to $46.6 million, though Adjusted EBITDA slightly declined to $5.6 million due to higher marketing and compensation costs.
• Profitability: Net loss narrowed by $14.1 million compared to the prior year, largely due to a $15.0 million gain from the change in fair value of warrant liabilities and a 49% reduction in interest expense following debt refinancing.
• Liquidity: Cash balances decreased by $21.4 million during the quarter, primarily due to operating losses and investing activities, partially offset by net financing inflows.

Guidance, Outlook, Risks, and Unusual Items

• Capital Structure Changes: In February 2025, the company issued $350.0 million of Senior Non-Convertible Preferred Stock. This instrument carries a 14.5% annual dividend rate (compounding if unpaid) and is classified as temporary equity. Proceeds were used to repay $260.0 million of Term Loans and fund operations.
• Warrant Liability: The company recorded a $15.0 million gain from the change in fair value of warrant liabilities, a non-cash item that significantly impacted the net loss. Warrants are classified as liabilities and marked to market quarterly.
• Legal Proceedings:
  • DOJ Action: The U.S. Attorney's Office intervened in a qui tam action alleging violations of the Federal False Claims Act regarding sales practices. The company denies allegations and is defending vigorously.
  • Securities Litigation: A consolidated securities class action lawsuit remains on appeal following a dismissal of the second amended complaint by the district court in April 2025.
• Outlook: Management expects existing cash, revolving credit facility availability, and operating cash flows to be sufficient for working capital and debt service needs for the next 12 months. The company is in compliance with all debt covenants.

Investor Verification Checklist

• Senior Segment Volatility: Verify the impact of Medicare regulatory changes on future policy approval rates and revenue stability in the Senior segment.
• Preferred Stock Obligations: Review the terms of the $350 million Senior Non-Convertible Preferred Stock, specifically the 14.5% dividend rate and redemption triggers, to assess future cash flow requirements.
• Warrant Liability Volatility: Monitor the fair value of warrant liabilities, as fluctuations significantly impact reported net income/loss without affecting cash flow.
• Legal Exposure: Track the status of the DOJ qui tam action and the securities class action appeal for potential material liabilities.
• Pharmacy Margins: Analyze the sustainability of the Healthcare Services segment's growth, given the 49% increase in Cost of Goods Sold alongside the 43% revenue increase.